GLP-1 receptor agonist use appeared linked to significantly reduced all-cause mortality among people with sickle cell disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback